Paper · 526011
Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice.
Descamps J and 6 others. Antimicrob Agents Chemother, 1979. Cited by 43 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice. Papers, record 526011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/526011
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Herpes Simplex | Major topic |
| Skin Diseases, Infectious | Major topic |
| Animals | |
| Mice | |
| Mice, Nude | |
| Thymus Gland |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 233,730 | 5-Propyl-2'-deoxyuridine: a specific anti-herpes agent. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/233730 | PubMed |
| 2 | 210,500 | Trisodium phosphonoformate, a new antiviral compound. | Science | 1978 | https://conductscience.org/library/papers/210500 | PubMed |
| 3 | 223,163 | (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/223163 | PubMed |
| 4 | 4,356,456 | Suppression of herpes simplex virus infection by phosphonoacetic acid. | Appl Microbiol | 1973 | https://conductscience.org/library/papers/4356456 | PubMed |
| 5 | 205,792 | 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. | Nature | 1978 | https://conductscience.org/library/papers/205792 | PubMed |
| 6 | 202,709 | 5-O-Alkylated derivatives of 5-hydroxy-2'-deoxyuridine as potential antiviral agents. Anti-herpes activity of 5-propynyloxy-2'-deoxyuridine. | J Med Chem | 1978 | https://conductscience.org/library/papers/202709 | PubMed |
| 7 | 736,794 | Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs. | Arch Virol | 1978 | https://conductscience.org/library/papers/736794 | PubMed |
| 8 | 213,015 | Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/213015 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,974,712 | Multiomics-guided discovery of protective microbiome signatures in lupus-prone mice treated with Faecalibacterium prausnitzii. | Nat Commun | 2026 | https://conductscience.org/library/papers/41974712 | PubMed |
| 10,602,719 | Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10602719 | PubMed |
| 7,352,751 | (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7352751 | PubMed |
| 7,137,983 | Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/7137983 | PubMed |
| 6,703,671 | Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6703671 | PubMed |
| 6,486,759 | Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6486759 | PubMed |
| 6,315,332 | Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. | Drugs | 1983 | https://conductscience.org/library/papers/6315332 | PubMed |
| 4,037,770 | Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4037770 | PubMed |
| 3,717,935 | Pharmacokinetics and metabolism of E-5-(2-[131I]iodovinyl)-2'-deoxyuridine in dogs. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3717935 | PubMed |
| 3,015,003 | Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3015003 | PubMed |
1 to 10 of 11
See all 11 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/526011
GET https://conductscience.org/api/papers/v1/526011/authors